Phospho-Aspirin (MDC-22) Prevents Pancreatic Carcinogenesis in Mice.
about
Nonsteroidal Anti-Inflammatory Therapy: A Journey Toward Safety.Phospho-valproic acid inhibits pancreatic cancer growth in mice: enhanced efficacy by its formulation in poly-(L)-lactic acid-poly(ethylene glycol) nanoparticles.Multipronged activity of combinatorial miR-143 and miR-506 inhibits Lung Cancer cell cycle progression and angiogenesis in vitro.
P2860
Phospho-Aspirin (MDC-22) Prevents Pancreatic Carcinogenesis in Mice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 May 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Phospho-Aspirin (MDC-22) Prevents Pancreatic Carcinogenesis in Mice.
@en
Phospho-Aspirin
@nl
type
label
Phospho-Aspirin (MDC-22) Prevents Pancreatic Carcinogenesis in Mice.
@en
Phospho-Aspirin
@nl
prefLabel
Phospho-Aspirin (MDC-22) Prevents Pancreatic Carcinogenesis in Mice.
@en
Phospho-Aspirin
@nl
P2093
P2860
P1476
Phospho-Aspirin (MDC-22) Prevents Pancreatic Carcinogenesis in Mice.
@en
P2093
Basil Rigas
Brandon M Vaeth
George Mattheolabakis
Gerardo G Mackenzie
Ioannis Papayannis
Jela Bandovic
Jennifer Yang
Nengtai Ouyang
Ruixue Wang
P2860
P304
P356
10.1158/1940-6207.CAPR-15-0344
P577
2016-05-02T00:00:00Z